Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

A child with rough nails also had hair loss and allergies.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Pregnancy can cause skin changes and conditions that need correct diagnosis and treatment for the health of the mother and baby.

Pregnancy can cause skin changes and affect existing skin conditions, with limited treatment options due to the need for fetal safety.

New treatments for hair loss show promise, but more development is needed, especially for tough cases.

Humans and pets share similar allergy mechanisms, and studying pet allergies can help treat both human and animal allergies.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Most pregnant women experience skin changes like darkening and stretch marks, and some may have skin conditions that usually get better after giving birth.

WNT10A mutations cause varied symptoms in patients with odonto-onycho-dermal dysplasia.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

COVID-19 can cause different skin issues, including rashes and hair loss.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Traumatic anserine folliculosis is a skin condition caused by friction, treatable with topical cream and avoiding trauma.

New understanding and treatments for hair loss are improving, but more research is needed.